ASPEN: Difference between revisions
Jump to navigation
Jump to search
←Redirected page to Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm |
No edit summary |
||
Line 1: | Line 1: | ||
#redirect:[[Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm]] | #redirect:[[Atorvastatin Study For The Prevention Of Endpoints For Patients With Niddm]] | ||
[[Category:Clinical trials]] |